diepoxybutane has been researched along with Myelodysplastic Syndromes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ghosh, K; Korgaonkar, S; Vundinti, BR | 1 |
| Guc-Scekic, M; Joksic, G; Joksic, I; Leskovac, A; Petrovic, S; Slijepcevic, P; Vujic, D | 1 |
2 other study(ies) available for diepoxybutane and Myelodysplastic Syndromes
| Article | Year |
|---|---|
Clinical, genetic and cytogenetic study of Fanconi anemia in an Indian population.
Topics: Adolescent; Carcinoma, Squamous Cell; Cells, Cultured; Child; Child, Preschool; Chromosome Breakage; Chromosome Fragility; Chromosomes, Human; Consanguinity; Epoxy Compounds; Fanconi Anemia; Female; Humans; India; Infant; Leukemia, Myeloid; Male; Mitomycin; Myelodysplastic Syndromes; Young Adult | 2010 |
Fanconi anemia is characterized by delayed repair kinetics of DNA double-strand breaks.
Topics: Adolescent; Apoptosis; Cells, Cultured; Child; Child, Preschool; Cross-Linking Reagents; Diagnosis, Differential; DNA Breaks, Double-Stranded; DNA Repair; Epoxy Compounds; Fanconi Anemia; Female; Fibroblasts; Fluorescent Antibody Technique, Indirect; Histones; Humans; Kinetics; Male; Myelodysplastic Syndromes; Predictive Value of Tests | 2010 |